Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it is the first contract research organization (CRO) chosen by the Korea Drug Development Fund (KDDF) to help Korean companies ...
read more
AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row...
read more
Ricerca Biosciences, an integrated preclinical pharmaceutical contract research organization (CRO), today announced the introduction of two new state-of-the-art cellular assay services: Early Safety Screening Cytotoxicity and ImmunoSIGNAL™ Cytokine ...
read more
CHEMISTRY CRO expert Onyx Scientific has announced a collaboration with a purification specialist that will see the company broaden its offering to the global pharmaceutical and biotech industry.
read more
ClinTec International, a leading global CRO with a substantial presence in the Middle East and Africa has expanded its operations into Malawi, appointing its first highly experienced clinical research associates.
read more
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based pharmaceutical company, today announced that Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of IGI Laboratories, Inc. effective July 30, 2012.
read more
Wednesday, August 01, 2012
Advanced BioScience Laboratories, Inc. (ABL, Inc.) announced today the award of a contract to provide the NIH National Institute of Allergy and Infectious Diseases (NIAID) with preclinical development and cGMP manufacturing support for multiple ...
read more
CoreRx, Inc. is pleased to announce they are now occupying their new 35,000 square foot facility in Clearwater, FL. This distinct facility will enable CoreRx’s scientific staff to custom formulate, analyze and manufacture the highest quality ...
read more
In this partnership, Gallus will provide process development and clinical and commercial supply for mammalian cell-based biopharmaceutical products to Theorem’s customers. In return, Theorem will offer contract research services to Gallus’ customers ...
read more
Pharmalucence, Inc has received FDA approvalexpanding the indication for use of its Sulfur Colloid Injection (SCI) to include localization oflymph nodes in malignant melanoma patients.
read more
WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a Certificate of Good Laboratory Practice (GLP) from the State Food and Drug Administration (SFDA) of the People's Republic of China after successfully ...
read more
Wednesday, August 22, 2012
Almac today announced that it is launching a Next Generation Sequencing service to further expand its range of solutions supporting the development of personalized medicine. The purpose of this service is to support Almac’s BioPharma partners in the ...
read more
Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization (CDMO) has created the Pharmatek Foundation, a not-for-profit organization supporting volunteerism for causes in the San Diego community. The Foundation's ...
read more
Tuesday, September 04, 2012
Cobra Biologics Ltd, the international clinical and commercial contract manufacturer of biologics and Algeta ASA a company focused on the development of novel targeted cancer therapeutics, announce a new contract manufacturing partnership for Algeta...
read more
Wednesday, September 05, 2012
Alphora is pleased to announce the completion of a GMP Kilo Laboratory, for the scale-up high potency, cytoctoxic compounds with occupational exposure limits (OEL’s) of 10µg/m3 or less. This expansion is a continuation of Alphora’s 2011 capital ...
read more